NSN 6505-01-252-0802 of Clorazepate Dipotassium Tablets - Parts Details
| Alternative NSN: 6505012520802 |
| Item Name: Clorazepate Dipotassium Tablets |
| FSG: 65 Medical Dental and Veterinary Equipment and Supplies |
| Federal Supply Class (FSC): 6505 Drugs and Biologicals |
| NIIN: 012520802 |
| NCB Code: USA (01) |
| Manufacturers: Taro Pharmaceuticals Usa Inc , Danbury Pharmacal Inc , Rugby Group Inc , Mylan Pharmaceuticals Inc , Schein Henry Inc , Actavis Inc , Abbott Laboratories Pharmaceutical Products Div , Warner Lambert Ltd |
ASAP Aviation Procurement, owned and operated by ASAP Semiconductor, is the latest parts procurement platform for the aerospace and aviation industry. Check out high demanding part numbers NDC51672-4042-02, NDC00591-0363-05, NDC00536-4940-05, NDC00378-0030-05, NDC00364-2201-05 under NSN 6505-01-252-0802 of Clorazepate Dipotassium Tablets manufactured by Taro Pharmaceuticals Usa Inc, Danbury Pharmacal Inc, Rugby Group Inc, Mylan Pharmaceuticals Inc, Schein Henry Inc.
Federal Supply Class of NSN 6505-01-252-0802 is FSC 6505 contains part details of Drugs and Biologicals. Quote for your desired part numbers.
Part Number's List for NSN 6505-01-252-0802, 6505012520802
-
Part No Manufacturer Item Name QTY RFQ NDC51672-4042-02 Taro Pharmaceuticals Usa Inc clorazepate dipotassium tablets Avl RFQ NDC00591-0363-05 Danbury Pharmacal Inc clorazepate dipotassium tablets Avl RFQ NDC00536-4940-05 Rugby Group Inc clorazepate dipotassium tablets Avl RFQ NDC00378-0030-05 Mylan Pharmaceuticals Inc clorazepate dipotassium tablets Avl RFQ NDC00364-2201-05 Schein Henry Inc clorazepate dipotassium tablets Avl RFQ NDC00228-3067-50 Actavis Inc clorazepate dipotassium tablets Avl RFQ NDC00074-4389-53 Abbott Laboratories Pharmaceutical Products Div clorazepate dipotassium tablets Avl RFQ NDC00047-0451-30 Warner Lambert Ltd clorazepate dipotassium tablets Avl RFQ 4389-53 Abbott Laboratories Pharmaceutical Products Div clorazepate dipotassium tablets Avl RFQ
Characteristics Data of NSN 6505012520802MRC Criteria Characteristic AJCN PROTECTIVE STORAGE FEATURE SECURITY STORAGE AKJA ACTIVE MEDICAMENT MEDICINAL STRENGTH 3.750 MILLIGRAMS CLORAZEPATE DIPOTASSIUM ACTIVE INGREDIENT CRLK PRIMARY CONTAINER CONTENT QUANTITY 500.000 TABLETS FEAT SPECIAL FEATURES SCHEDULE IV CONTROLLED SUBSTANCE CLASSIFICATION CXCY PART NAME ASSIGNED BY CONTROLLING AGENCY CLORAZEPATE DIPOTASSIUM TABLETS 3.75MG 500S BT CQCT PRIMARY CONTAINER TYPE BOTTLE
| MRC | Criteria | Characteristic |
|---|---|---|
| AJCN | PROTECTIVE STORAGE FEATURE | SECURITY STORAGE |
| AKJA | ACTIVE MEDICAMENT MEDICINAL STRENGTH | 3.750 MILLIGRAMS CLORAZEPATE DIPOTASSIUM ACTIVE INGREDIENT |
| CRLK | PRIMARY CONTAINER CONTENT QUANTITY | 500.000 TABLETS |
| FEAT | SPECIAL FEATURES | SCHEDULE IV CONTROLLED SUBSTANCE CLASSIFICATION |
| CXCY | PART NAME ASSIGNED BY CONTROLLING AGENCY | CLORAZEPATE DIPOTASSIUM TABLETS 3.75MG 500S BT |
| CQCT | PRIMARY CONTAINER TYPE | BOTTLE |